Although mutations in LNK are not commonly found as drivers of MPNs, evidence has emerged that there is an overrepresentation of LNK mutations in blast-phase MPN, suggesting a role in leukemic transformation13,14. This evidence concerns the gene SH2B3 and myeloproliferative neoplasm.